Pharmaceutical composition and application thereof in treating acute myelitis
A composition and a technique for myelitis, applied in the field of medicine, can solve the problems of large side effects, unsatisfactory effect, long medication time, etc., and achieve the effects of promoting the generation of neurotransmitters, enhancing the immunity of the body, and recovering the cell function.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0012] Calculated by weight, the pharmaceutical composition comprises 15 parts of notoginsenoside R1, 5 parts of naringin, 9 parts of salicin and 1 part of α-pinene.
Embodiment 2
[0014] Calculated by weight, the pharmaceutical composition comprises 16 parts of notoginsenoside R1, 6 parts of naringin, 11 parts of salicin and 2 parts of α-pinene.
Embodiment 3
[0016] Calculated by weight, the pharmaceutical composition comprises 10 parts of notoginsenoside R1, 4 parts of naringin, 8 parts of salicin and 6 parts of α-pinene.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com